Published in Hum Genet on August 01, 1994
Lynch syndrome genes. Fam Cancer (2005) 1.94
Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management. Mol Oncol (2009) 1.61
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Regulation of cell death protease caspase-9 by phosphorylation. Science (1998) 11.26
Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics (1992) 9.06
Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature (1994) 8.04
Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell (1990) 4.60
Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst (2001) 4.14
Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature (1988) 3.96
Prediction of the risk of hereditary retinoblastoma, using DNA polymorphisms within the retinoblastoma gene. N Engl J Med (1988) 3.90
Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes. Genes Chromosomes Cancer (1992) 3.03
Growth inhibition test for identification of Mycoplasma species utilizing dried antiserum-impregnated paper discs. J Bacteriol (1967) 2.83
Loss of constitutional heterozygosity in human cancer. Annu Rev Genet (1991) 2.77
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75
Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab (1997) 2.73
Clinical and genetic studies of Birt-Hogg-Dubé syndrome. J Med Genet (2002) 2.65
Mycoplasmas and cell cultures. Bacteriol Rev (1971) 2.41
Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet (1993) 2.37
Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet (1994) 2.28
Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Oncogene (1997) 1.97
Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat (1997) 1.88
Birt-Hogg-Dubé syndrome: mapping of a novel hereditary neoplasia gene to chromosome 17p12-q11.2. Oncogene (2001) 1.81
Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci U S A (2001) 1.80
A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers. Genes Chromosomes Cancer (1998) 1.79
Detection of chromosomal imbalances in children with idiopathic mental retardation by array based comparative genomic hybridisation (array-CGH). J Med Genet (2005) 1.79
Isolation and identification of mycoplasma from human clinical materials. Ann N Y Acad Sci (1967) 1.79
Novel filaggrin mutation but no other loss-of-function variants found in Ethiopian patients with atopic dermatitis. Br J Dermatol (2011) 1.77
Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia. Blood (1998) 1.73
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62
Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome. Bone Marrow Transplant (2010) 1.59
Distinct and overlapping ligand specificities of the alpha 3A beta 1 and alpha 6A beta 1 integrins: recognition of laminin isoforms. Mol Biol Cell (1994) 1.56
Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet (2001) 1.53
Frequent amplification of the telomerase reverse transcriptase gene in human tumors. Cancer Res (2000) 1.52
Loss of heterozygosity in human ductal breast tumors indicates a recessive mutation on chromosome 13. Proc Natl Acad Sci U S A (1987) 1.47
Colorectal cancer with and without microsatellite instability involves different genes. Genes Chromosomes Cancer (1999) 1.44
Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Res (1996) 1.43
Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer (2009) 1.38
Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer. Gut (2002) 1.38
Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci U S A (1990) 1.36
Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor. Br J Cancer (1999) 1.36
Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis (2001) 1.36
High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium. Genes Chromosomes Cancer (1995) 1.34
Differential expression of aquaporin 8 in human colonic epithelial cells and colorectal tumors. BMC Physiol (2001) 1.32
Association studies on 11 published colorectal cancer risk loci. Br J Cancer (2010) 1.31
A rare CYP19 (aromatase) variant may increase the risk of breast cancer. Pharmacogenetics (1998) 1.30
Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. Proc Natl Acad Sci U S A (1987) 1.30
Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy. Haemophilia (2013) 1.27
The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res (2001) 1.20
Microsatellite Instability and hMLH1 and hMSH2 expression analysis in familial and sporadic colorectal cancer. Lab Invest (2001) 1.19
Linkage analysis in a large Swedish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 9q22.32-31.1. J Med Genet (2006) 1.18
Mutation screening in the hMLH1 gene in Swedish hereditary nonpolyposis colon cancer families. Cancer Res (1995) 1.17
Deletion mapping in human renal cell carcinoma. Cancer Res (1989) 1.17
Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells. Oncogene (2001) 1.17
Anticholinergic medication in diagnostic endoscopy of the upper gastrointestinal tract. Endoscopy (1991) 1.16
Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy (2006) 1.16
Various mutation screening techniques in the DNA mismatch repair genes hMSH2 and hMLH1. Genet Test (1999) 1.14
The role of ataxia-telangiectasia heterozygotes in familial breast cancer. Cancer Res (1998) 1.14
The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study. Fam Cancer (2001) 1.13
Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res (1990) 1.13
Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet (1993) 1.13
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. Cancer Res (1998) 1.12
A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. Br J Cancer (2010) 1.11
A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome. J Med Genet (2008) 1.11
Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics. Haemophilia (2013) 1.11
A study of the PTEN/MMAC1 gene in 136 breast cancer families. Hum Genet (1998) 1.10
COL11A1 in FAP polyps and in sporadic colorectal tumors. BMC Cancer (2001) 1.10
High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer. J Med Genet (2005) 1.10
The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-kappaB signaling pathways. Oncogene (2010) 1.10
Germline mutations in the MYH gene in Swedish familial and sporadic colorectal cancer. Genet Test (2005) 1.10
Tetrasomy 15q: two marker chromosomes with no detectable alpha-satellite DNA. Am J Hum Genet (1994) 1.09
ATM mutations in cancer families. Cancer Res (1996) 1.09
Complete characterization of a large marker chromosome by reverse and forward chromosome painting. Hum Genet (1992) 1.09
Spectrum and clinical implications of syntaxin 11 gene mutations in familial haemophagocytic lymphohistiocytosis: association with disease-free remissions and haematopoietic malignancies. J Med Genet (2006) 1.09
Oral sedation for diagnostic upper endoscopy. Endoscopy (1991) 1.08
Central nervous system involvement in severe congenital neutropenia: neurological and neuropsychological abnormalities associated with specific HAX1 mutations. J Intern Med (2008) 1.08
MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer. Cancer Res (2001) 1.06
Tumorigenesis in colorectal tumors from patients with hereditary non-polyposis colorectal cancer. Hum Genet (1997) 1.06
Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps. Gut (2003) 1.06
Spectrum, and clinical and functional implications of UNC13D mutations in familial haemophagocytic lymphohistiocytosis. J Med Genet (2007) 1.06
Swedish survey on extra structurally abnormal chromosomes in 39 105 consecutive prenatal diagnoses: prevalence and characterization by fluorescence in situ hybridization. Prenat Diagn (1994) 1.06
Virtual reality colonoscopy simulation: a compulsory practice for the future colonoscopist? Endoscopy (2005) 1.05
Susceptibility loci for atopic dermatitis on chromosomes 3, 13, 15, 17 and 18 in a Swedish population. Hum Mol Genet (2002) 1.05
Increased frequency of sister chromatid exchanges in cigarette smokers. Hereditas (1978) 1.04
A germline E-cadherin mutation in a family with gastric and colon cancer. Int J Mol Med (2001) 1.04
Predisposition for breast cancer in carriers of constitutional translocation 11q;22q. Am J Hum Genet (1994) 1.04
Characterization of supernumerary ring marker chromosomes by fluorescence in situ hybridization (FISH). Am J Hum Genet (1993) 1.04
Low frequency of E-cadherin alterations in familial breast cancer. Breast Cancer Res (2001) 1.04
A map of 22 loci on human chromosome 22. Genomics (1991) 1.04
Microsatellite instability as a predictor of a mutation in a DNA mismatch repair gene in familial colorectal cancer. Genes Chromosomes Cancer (2000) 1.04
Classification of colorectal polyps: guidelines for the endoscopist. Endoscopy (2002) 1.03
Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC. J Med Genet (2004) 1.03
Strand-break formation in DNA modified by benzo[alpha]pyrene diolepoxide. Quantitative cleavage by Escherichia coli uvrABC endonuclease. Mutat Res (1983) 1.02
Hypermethylation of Ron proximal promoter associates with lack of full-length Ron and transcription of oncogenic short-Ron from an internal promoter. Oncogene (2007) 1.02
Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma. Int J Cancer (2000) 1.01
Loss of heterozygosity in familial breast carcinomas. Cancer Res (1993) 1.00
Detailed physical map of human chromosomal region 11q12-13 shows high meiotic recombination rate around the MEN1 locus. Proc Natl Acad Sci U S A (1991) 1.00